PRNewsWire - Health - Latest News Search Engine - Global and Local Breaking News

PRNewsWire - Health

Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, L...

MR-142 Achieved Primary Endpoint of ≥15-letter (≥3-line) Gain in Mesopic Low Contrast Distance Visual Acuity in Comparison to Placebo Results Showed P...

$Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions$

REGENXBIO to Host Webcast Discussing Interim Functional Data from the Phase I/II AFFINITY DUCHENNE® Trial of RGX-202

Event will feature Aravindhan Veerapandiyan, M.D., principal investigator of the AFFINITY DUCHENNE® trial ROCKVILLE, Md., June 2, 2025 /PRNewswire/ --...

REGENXBIO to Host Webcast Discussing Interim Functional Data from the Phase I/II AFFINITY DUCHENNE® Trial of RGX-202

USANA Executive Chairman Kevin Guest Celebrates National Outdoors Month with a Call to Reconnect with Nature

SALT LAKE CITY, June 2, 2025 /PRNewswire/ -- Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE: USNA), is inspiring individuals and famil...

USANA Executive Chairman Kevin Guest Celebrates National Outdoors Month with a Call to Reconnect with Nature

Grünenthal announces acquisition of the rights to Cialis® from Lilly in Mexico, Brazil & Colombia

Grünenthal announces that it agreed to acquire the commercial rights to Cialis® from Eli Lilly and Company in Mexico, Brazil and Colombia, further str...

Grünenthal announces acquisition of the rights to Cialis® from Lilly in Mexico, Brazil & Colombia